BRPI0511355A - composição para aplicação tópica na pele de mamìferos, seu uso, métodos para confecção de composições, método para o tratamento da psorìase e método para o tratamento do eczema - Google Patents
composição para aplicação tópica na pele de mamìferos, seu uso, métodos para confecção de composições, método para o tratamento da psorìase e método para o tratamento do eczemaInfo
- Publication number
- BRPI0511355A BRPI0511355A BRPI0511355-5A BRPI0511355A BRPI0511355A BR PI0511355 A BRPI0511355 A BR PI0511355A BR PI0511355 A BRPI0511355 A BR PI0511355A BR PI0511355 A BRPI0511355 A BR PI0511355A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- treating
- eczema
- mammalian skin
- methods
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 6
- 201000004624 Dermatitis Diseases 0.000 title abstract 3
- 201000004681 Psoriasis Diseases 0.000 title abstract 3
- 208000010668 atopic eczema Diseases 0.000 title abstract 3
- 230000000699 topical effect Effects 0.000 title abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
COMPOSIçãO PARA APL1ICAçãO TóPICA NA PELE DE MAMìFEROS, SEU USO, MéTODOS PARA CONFECçãO DE COMPOSIçõES, MéTODO PARA O TRATAMENTO DA PSORìASE E MéTODO PARA O TRATAMENTO DO ECZEMA. São descritas composições para tratamento tópico da pele de mamíferos, particularmente da pele humana, que aliviam os sintomas dolorosos de muitas doenças de pele e propiciam, em muitos casos, uma cura em longo prazo. A composição compreende, em combinação, um ou mais ácidos boswélicos e/ou um ácido graxo que tem um comprimento de cadeia de pelo menos 18 átomos de carbono e que contém pelo menos duas ligações insaturadas junto com um sistema antibacteriano à base de enzima. As composições reduzirão de modo seletivo a proliferação da célula e podem ser usadas para o tratamento do eczema e/ou da psoríase.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0413954.9A GB0413954D0 (en) | 2004-06-22 | 2004-06-22 | Compositions for topical treatment |
PCT/IB2005/001692 WO2006000867A1 (en) | 2004-06-22 | 2005-06-16 | Compositions for topical treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0511355A true BRPI0511355A (pt) | 2007-12-04 |
Family
ID=32799947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0511355-5A BRPI0511355A (pt) | 2004-06-22 | 2005-06-16 | composição para aplicação tópica na pele de mamìferos, seu uso, métodos para confecção de composições, método para o tratamento da psorìase e método para o tratamento do eczema |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070253943A1 (pt) |
EP (1) | EP1776128B1 (pt) |
JP (1) | JP2008503558A (pt) |
KR (1) | KR20070040369A (pt) |
CN (1) | CN1972708A (pt) |
AU (1) | AU2005256908A1 (pt) |
BR (1) | BRPI0511355A (pt) |
CA (1) | CA2571444A1 (pt) |
EA (1) | EA011723B1 (pt) |
GB (5) | GB0413954D0 (pt) |
IL (1) | IL180091A0 (pt) |
IN (1) | IN2006DE07403A (pt) |
MX (1) | MXPA06014787A (pt) |
WO (1) | WO2006000867A1 (pt) |
ZA (1) | ZA200700012B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITVR20080125A1 (it) * | 2008-11-13 | 2010-05-14 | Phytonature Sas Di Masini Dr Antoni O E C | Nuova forma di preparazione ed utilizzo della boswellia serrata |
WO2010106417A2 (en) * | 2009-03-16 | 2010-09-23 | Himalaya Global Holdings Ltd. | Herbal personal care formulations and method of preparing the same |
CN101721340B (zh) * | 2009-10-23 | 2012-02-15 | 无限极(中国)有限公司 | 一种用于延缓肌肤衰老的化妆品组合物 |
US20130004477A1 (en) * | 2009-10-26 | 2013-01-03 | Zhe Lu | Methods for Treating Inflammation and Oxidative Stress Related Diseases |
DK2366408T3 (da) * | 2010-03-01 | 2012-10-22 | Salvat Lab Sa | Vandige, klare opløsninger af fluocinolonacetonid til behandling af inflammation i øret |
PL2444081T3 (pl) * | 2010-10-19 | 2015-09-30 | Parenteral A S | Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol |
WO2012177825A1 (en) | 2011-06-21 | 2012-12-27 | Bvw Holding Ag | Medical device comprising boswellic acid |
ITUA20162425A1 (it) * | 2016-04-08 | 2017-10-08 | Medivis S R L | Composizione oftalmica che comprende PVP-I |
US9975917B1 (en) | 2017-09-20 | 2018-05-22 | King Saud University | Pentacyclic triterpenoidal derivatives |
GB2584647A (en) * | 2019-06-06 | 2020-12-16 | Boston Healthcare Ltd | Skin treatment composition |
BE1028576B1 (fr) * | 2021-12-30 | 2023-08-17 | Dyna S A R L | Composition comprenant au moins un acide boswellique et/ou au moins un extrait végétal comprenant au moins un acide boswellique pour utilisation topique dans le traitement des maladies inflammatoires de la peau |
WO2023187598A1 (en) * | 2022-03-27 | 2023-10-05 | Biblical Lands Ltd | Compositions and methods |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9002422D0 (en) * | 1990-02-03 | 1990-04-04 | Boots Co Plc | Anti-microbial compositions |
GB9127062D0 (en) * | 1991-12-20 | 1992-02-19 | Unilever Plc | Lip treatment composition |
FR2685202B1 (fr) * | 1991-12-24 | 1995-03-24 | Sederma Sa | Nouvelle methode de traitement pharmaceutique et cosmetique pour la regulation de la seborrhee, de l'acne et de la flore cutanee. |
DE4201903B4 (de) * | 1992-01-24 | 2004-04-15 | Hermann P.T. Prof. Dr.Med. Ammon | Pharmazeutische Verwendung von Boswelliasäuren |
JP3746081B2 (ja) | 1994-02-24 | 2006-02-15 | 森永乳業株式会社 | 動物皮膚病治療剤 |
JP3888707B2 (ja) * | 1996-01-22 | 2007-03-07 | 森永乳業株式会社 | 血管新生病治療剤 |
NO965344A (no) * | 1996-07-29 | 1997-11-24 | Risa Bjoern Gunnar | Oppspolingsanordning, særlig for oppspoling av lastestropper |
US5972355A (en) * | 1997-09-30 | 1999-10-26 | E-L Management Corp. | Stable compositions containing biologically active components |
AU753232B2 (en) * | 1998-10-15 | 2002-10-10 | Dsm N.V. | Antimicrobial enzymes in animal feed |
GB9906914D0 (en) | 1999-03-26 | 1999-05-19 | Quest Int | Compositions containing boswellia extracts |
EP1173162A1 (en) * | 1999-04-30 | 2002-01-23 | Sabinsa Corporation | Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
US6214339B1 (en) * | 2000-01-12 | 2001-04-10 | Michael A. Pellico | Di-enzymatic treatment of outer ear infection in dogs and cats |
PT1272154E (pt) * | 2000-04-04 | 2004-11-30 | Color Access Inc | Composicao para melhorar a funcao da barreira lipidica da pele |
GB0100643D0 (en) * | 2001-01-10 | 2001-02-21 | Basf Ag | Liquid antimicrobial compositions |
WO2002085921A2 (de) * | 2001-03-01 | 2002-10-31 | Johann Jauch | Einfaches verfahren zur synthese von boswelliasäuren und derivaten davon |
NL1018421C1 (nl) * | 2001-06-29 | 2003-01-07 | Sara Lee De Nv | Mondverzorgingsmiddel. |
JP2003089629A (ja) * | 2001-09-18 | 2003-03-28 | Kakunai Juyotai Kenkyusho:Kk | 新規化粧品、新規外用剤及び新規浴剤の製造方法 |
US20030211995A1 (en) | 2001-12-21 | 2003-11-13 | Kokai-Kun John Fitzgerald | Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
ATE519499T1 (de) * | 2002-05-10 | 2011-08-15 | Agennix Inc | Lactoferrin bei der behandlung maligner neoplasien und anderer hyperproliferativer erkrankungen |
US20040214750A1 (en) * | 2003-04-28 | 2004-10-28 | Georgiades Izolda M. | Medicaments for healing skin conditions in humans |
US20070264222A1 (en) * | 2006-05-10 | 2007-11-15 | Biohealth Advance, Llc | Enhanced protection against skin injury in humans |
-
2004
- 2004-06-22 GB GBGB0413954.9A patent/GB0413954D0/en not_active Ceased
-
2005
- 2005-06-16 US US11/570,806 patent/US20070253943A1/en not_active Abandoned
- 2005-06-16 GB GB0625339A patent/GB2430884B/en not_active Expired - Fee Related
- 2005-06-16 EA EA200700044A patent/EA011723B1/ru not_active IP Right Cessation
- 2005-06-16 EP EP05753109.7A patent/EP1776128B1/en active Active
- 2005-06-16 KR KR1020077000578A patent/KR20070040369A/ko not_active Application Discontinuation
- 2005-06-16 CN CNA2005800203645A patent/CN1972708A/zh active Pending
- 2005-06-16 CA CA002571444A patent/CA2571444A1/en not_active Abandoned
- 2005-06-16 JP JP2007517511A patent/JP2008503558A/ja active Pending
- 2005-06-16 MX MXPA06014787A patent/MXPA06014787A/es not_active Application Discontinuation
- 2005-06-16 AU AU2005256908A patent/AU2005256908A1/en not_active Abandoned
- 2005-06-16 GB GB0820552A patent/GB2451597B/en not_active Expired - Fee Related
- 2005-06-16 BR BRPI0511355-5A patent/BRPI0511355A/pt not_active IP Right Cessation
- 2005-06-16 GB GB0800351A patent/GB2445674B/en not_active Expired - Fee Related
- 2005-06-16 WO PCT/IB2005/001692 patent/WO2006000867A1/en active Application Filing
-
2006
- 2006-12-07 IN IN7403DE2006 patent/IN2006DE07403A/en unknown
- 2006-12-14 IL IL180091A patent/IL180091A0/en unknown
-
2007
- 2007-01-02 ZA ZA200700012A patent/ZA200700012B/en unknown
-
2008
- 2008-10-01 GB GBGB0817929.3A patent/GB0817929D0/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU2005256908A1 (en) | 2006-01-05 |
GB0413954D0 (en) | 2004-07-28 |
GB2451597B (en) | 2009-03-25 |
GB2430884B (en) | 2008-03-19 |
ZA200700012B (en) | 2008-04-30 |
US20070253943A1 (en) | 2007-11-01 |
EP1776128B1 (en) | 2018-02-14 |
GB2430884A (en) | 2007-04-11 |
GB2451597A (en) | 2009-02-04 |
WO2006000867B1 (en) | 2006-05-18 |
GB2445674B (en) | 2009-02-18 |
JP2008503558A (ja) | 2008-02-07 |
GB0820552D0 (en) | 2008-12-17 |
MXPA06014787A (es) | 2007-03-12 |
CN1972708A (zh) | 2007-05-30 |
GB0625339D0 (en) | 2007-02-07 |
CA2571444A1 (en) | 2006-01-05 |
GB0817929D0 (en) | 2008-11-05 |
IL180091A0 (en) | 2007-07-04 |
IN2006DE07403A (pt) | 2007-08-31 |
EP1776128A1 (en) | 2007-04-25 |
KR20070040369A (ko) | 2007-04-16 |
EA011723B1 (ru) | 2009-04-28 |
EA200700044A1 (ru) | 2007-08-31 |
GB2445674A (en) | 2008-07-16 |
GB0800351D0 (en) | 2008-02-20 |
WO2006000867A1 (en) | 2006-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0511355A (pt) | composição para aplicação tópica na pele de mamìferos, seu uso, métodos para confecção de composições, método para o tratamento da psorìase e método para o tratamento do eczema | |
BR0015604A (pt) | Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas | |
BR0314710A (pt) | Terapia profilática com ácido decosahexenóico para pacientes com inflamação subclìnica | |
BRPI0507895A (pt) | composição para o tratamento de insuficiências venosas crÈnicas, compreendendo um extrato de folhas de videira-vermelha e um agente antiinflamatório | |
BRPI0410503A (pt) | uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição | |
BR9911656A (pt) | Composição farmacêutica, processos para prevenção ou tratamento de diabetes em um mamìfero, para prevenção ou tratamento de complicações diabéticas em um mamìfero e para prevenção ou tratamento da tolerância a glicose prejudicada em um mamìfero, uso de um sensibilizador de insulina, e, proceso para reduzir os efeitos colaterais de um sensibilizador de insulina ou/ e um anorético administrado a um mamìfero diabético | |
BRPI0409348A (pt) | formulações e métodos para tratamento de rinossinusite | |
BR0114927A (pt) | Composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição | |
BR112017015773A2 (pt) | muteína de lipocalina, muteína de hngal, molécula de ácido nucleico, célula hospedeira, método para produzir a muteína de hngal, composição farmacêutica, kit, uso da muteína de hngal, uso da muteína de hngal, método para ligar ang-2 em um indivíduo, método para inibir angiogênese em um indivíduo, método para tratar, prevenir ou melhorar uma doença e método para inibir ou reduzir angiogênese em um indivíduo | |
BR9916450A (pt) | Composição tópica, método cosmético para tratar e/ ou prevenir condições de pele, e, uso de ácido linoleico conjugado, e/ ou derivados do mesmo | |
BR9507793A (pt) | Composição anti-microbiana tendo propriedades anti-corrosivas pré-mistura para fazer uma composição anti-microbiana método de fazer uma composição anti-microbiana tendo propriedades anti-corrosiva e método de reprocessar um cateter | |
BRPI0508410A (pt) | composições e métodos para a aplicação tópica e liberação transdérmica de toxinas botulìnicas | |
BR9808109A (pt) | Inibidor terapêutico de células vasculares da musculatura lisa | |
BR0116369A (pt) | Composto, método para a profilaxia ou o tratamento de uma condição clìnica em um mamìfero, formulação farmacêutica, uso de um composto, e, processo para preparar composto | |
BRPI0706676B8 (pt) | uso de uma solução aquosa com potencial de oxirredução | |
BR0013081A (pt) | Pirimidino-2,4,6-trionas inibidoras de metaloproteinases | |
BR9710918A (pt) | Método de tratamento ou redução de isquemia de miocárdio ou doença arteriocoronária ou acidentes cardiovasculares e uso de progesterona e polìmero de ácido mpolicarboxìlico de ligação cruzada. | |
NO20005718D0 (no) | Sammensetning for hud | |
BR0109672A (pt) | Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente | |
WO2006021660A8 (fr) | Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation | |
BR9811923A (pt) | Compostos possuindo atividade neuronal | |
PE20212158A1 (es) | Composicion farmaceutica acuosa de anticuerpo anti-il17a y su uso | |
BR0212576A (pt) | Método para o tratamento de distúrbios da pele | |
BRPI0516556A (pt) | certas plantas com nìveis "não saturados"ou reduzidos de ácidos graxos nas sementes e óleo derivado das sementes | |
BRPI0606528A8 (pt) | composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2257 DE 08/04/2014. |